2025 annual financial data
Neuphoria Therapeutics 2025 Operating margin
Direct answer
Operating margin was -7.21%.
Operating income was -1,129,091 USD and net income was -369,632 USD.
Operating cash flow was 77,229,000 USD.
Get free Neuphoria Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 15,649,448 USD
- Operating income
- -1,129,091 USD
- Net income
- -369,632 USD
- Operating cash flow
- 77,229,000 USD